Corporate News

Updated Notice of Results & Investor Presentation via Investor Meet Company

17 August 2026

Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces an updated date for the publication of its Audited Results for the year ended 31 March 2026 which will now be Tuesday, 8 September 2026. This delay is due to auditor and Company bandwidth in the audit process. The Board reiterates its expectation that revenue, EBITDA and cash remain in line with market expectations as reported.

Investor Presentation:

On the same day at 14:30 BST, James Cooper (Chief Executive Officer) and Ajay Patel (Chief Financial Officer) will host a live online presentation via the Investor Meet Company ("IMC") platform to discuss the results.

The presentation is open to all existing and potential shareholders. Questions can be submitted in advance via the IMC dashboard up until 09:00 BST on 7 September 2026, or during the live event.

To register for the event and add Cambridge Nutritional Sciences plc to your watchlist, please visit:

https://www.investormeetcompany.com/cambridge-nutritional-sciences-plc/register-investor

Shareholders who already follow Cambridge Nutritional Sciences plc on the IMC platform will be automatically invited to the presentation.

 

Contacts: 

Cambridge Nutritional Sciences plc        

www.cnsplc.com

Carolyn Rand, Non-Executive Chair

investors@cnsplc.com

James Cooper, Chief Executive Officer

 

Ajay Patel, Chief Financial Officer

 

 

Cavendish Capital Markets Limited    

 

Tel: 020 7220 0500

Geoff Nash / Edward Whiley / (Corporate Finance)

 

Nigel Birks / Harriet Ward (ECM)

 

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

Sign up for Investor Alerts